PSIVIDA ANNOUNCES COLLABORATION WITH CIRRUS PHARMACEUTICALS

Global nanotechnology company pSivida Limited (NASDAQ:PSDV, ASX:PSD, Xetra:PSI) today announced that it has signed a contract with US based Cirrus Pharmaceuticals, Inc. to accelerate and expand development of a number of specific drug candidates formulated in BioSilicon(TM)to expand a BioSilicon product pipeline of reformulated drugs. The development contract will have an initial extendable term of one year and provide a dedicated team of scientists from Cirrus Pharmaceuticals.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1047791XSL_NEWSML_TO_NEWSML_WEB.xml)